Osteoinductivity of demineralized bone matrix in immunocompromised mice and rats is decreased by ovariectomy and restored by estrogen replacement

Bone

Volumn 40, Issue 1, 2007, Pages 111-121

  McMillan, J ^a   Kinney, R C ^a   Ranly, D M ^a   Fatehi Sedeh, S ^a   Schwartz, Z ^a,b   Boyan, B D ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Demineralized bone matrix; Estrogen replacement; Osteoinduction; Ovariectomized mice and rats

Indexed keywords

ESTRADIOL; ESTROGEN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE GRAFT; BONE MARROW; BONE MATRIX; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DRUG EFFICACY; DRUG RELEASE; ENCHONDRAL OSSIFICATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GASTROCNEMIUS MUSCLE; HISTOLOGY; IMMUNE DEFICIENCY; IMPLANT; MORPHOMETRICS; MOUSE; NONHUMAN; NUDE MOUSE; OSSIFICATION; OVARIECTOMY; QUALITATIVE ANALYSIS; RAT; RAT STRAIN; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; UTERUS WEIGHT; XENOGRAFT;

ANIMALS; BONE MATRIX; CARTILAGE; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MICE; MICE, NUDE; MUSCLE, SKELETAL; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33751538554     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.07.022     Document Type: Article

References (63)

1. Cornell C.N., Lane J.M., and Poynton A.R. Orthopedic management of vertebral and long bone fractures in patients with osteoporosis. Clin. Geriatr. Med. 19 (2003) 433-455
2. Tiedeman J.J., Garvin K.L., Kile T.A., and Connolly J.F. The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics 18 (1995) 1153-1158
3. Price C.T., Connolly J.F., Carantzas A.C., and Ilyas I. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis. Spine 28 (2003) 793-798
4. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
5. Van de Putte K.A., and Urist M.R. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix. Clin. Orthop. Relat. Res. 43 (1965) 257-270
6. McCarthy K.F., Wientroub S., Hale M., and Reddi A.H. Establishment of the hematopoietic microenvironment in the marrow of matrix-induced endochondral bone. Exp. Hematol. 12 (1984) 131-138
7. Honsawek S., Powers R.M., and Wolfinbarger L. Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model. Cell Tissue Bank 6 (2005) 13-23
8. Torricelli P., Fini M., Rocca M., Giavaresi G., and Giardino R. Xenogenic demineralized bone matrix: osteoinduction and influence of associated skeletal defects in heterotopic bone formation in rats. Int. Orthop. 23 (1999) 178-181
9. Chesmel K.D., Branger J., Wertheim H., and Scarborough N. Healing response to various forms of human demineralized bone matrix in athymic rat cranial defects. J. Oral Maxillofac. Surg. 56 (1998) 857-863 (discussion 64-5)
10. Becker W., Urist M.R., Tucker L.M., Becker B.E., and Ochsenbein C. Human demineralized freeze-dried bone: inadequate induced bone formation in athymic mice. A preliminary report. J. Periodontol. 66 (1995) 822-828
11. Block J.E., and Poser J. Does xenogeneic demineralized bone matrix have clinical utility as a bone graft substitute?. Med. Hypotheses 45 (1995) 27-32
12. Ripamonti U., Magan A., Ma S., van den Heever B., Moehl T., and Reddi A.H. Xenogeneic osteogenin, a bone morphogenetic protein, and demineralized bone matrices, including human, induce bone differentiation in athymic rats and baboons. Matrix 11 (1991) 404-411
13. Nathan R.M., Bentz H., Armstrong R.M., Piez K.A., Smestad T.L., Ellingsworth L.R., et al. Osteogenesis in rats with an inductive bovine composite. J. Orthop. Res. 6 (1988) 324-334
14. Liang G., Yang Y., Oh S., Ong J.L., Zheng C., Ran J., et al. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice. Biomaterials 26 (2005) 4265-4271
15. Pekkarinen T., Lindholm T.S., Hietala O., and Jalovaara P. The effect of different mineral frames on ectopic bone formation in mouse hind leg muscles induced by native reindeer bone morphogenetic protein. Arch. Orthop. Trauma Surg. 125 (2005) 10-15
16. Ranly D.M., McMillan J., Keller T., Lohmann C.H., Meunch T., Cochran D.L., et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J. Bone Jt. Surg., Am. 87 (2005) 2052-2064
17. Schwartz Z., Weesner T., van Dijk S., Cochran D.L., Mellonig J.T., Lohmann C.H., et al. Ability of deproteinized cancellous bovine bone to induce new bone formation. J. Periodontol. 71 (2000) 1258-1269
18. Zhang M., Powers Jr. R.M., and Wolfinbarger Jr. L. A quantitative assessment of osteoinductivity of human demineralized bone matrix. J. Periodontol. 68 (1997) 1076-1084
19. Han B., Yang Z., and Nimni M. Effects of moisture and temperature on the osteoinductivity of demineralized bone matrix. J. Orthop. Res. 23 (2005) 855-861
20. Lohmann C.H., Andreacchio D., Koster G., Carnes Jr. D.L., Cochran D.L., Dean D.D., et al. Tissue response and osteoinduction of human bone grafts in vivo. Arch. Orthop. Trauma Surg. 121 (2001) 583-590
21. McCauley L.K., Rosol T.J., Capen C.C., and Horton J.E. A comparison of bone turnover in athymic (nude) and euthymic mice: biochemical, histomorphometric, bone ash and in vitro studies. Bone 10 (1989) 29-34
22. Strates B.S., Stock A.J., and Connolly J.F. Skeletal repair in the aged: a preliminary study in rabbits. Am. J. Med. Sci. 296 (1988) 266-269
23. Nishimoto S.K., Chang C.H., Gendler E., Stryker W.F., and Nimni M.E. The effect of aging on bone formation in rats: biochemical and histological evidence for decreased bone formation capacity. Calcif. Tissue Int. 37 (1985) 617-624
24. Bessho K., and Iizuka T. Changes in bone inducing activity of bone morphogenetic protein with aging. Ann. Chir. Gynaecol. Suppl. 207 (1993) 49-53
25. Torricelli P., Fini M., Giavaresi G., Rimondini L., and Giardino R. Characterization of bone defect repair in young and aged rat femur induced by xenogenic demineralized bone matrix. J. Periodontol. 73 (2002) 1003-1009
26. Syftestad G.T., and Urist M.R. Bone aging. Clin. Orthop. Relat. Res. (1982) 288-297
27. Capanna R., Donati D., Masetti C., Manfrini M., Panozzo A., Cadossi R., et al. Effect of electromagnetic fields on patients undergoing massive bone graft following bone tumor resection. A double blind study. Clin. Orthop. Relat. Res. (1994) 213-221
28. Ciombor D.M., Lester G., Aaron R.K., Neame P., and Caterson B. Low frequency EMF regulates chondrocyte differentiation and expression of matrix proteins. J. Orthop. Res. 20 (2002) 40-50
29. Torricelli P., Fini M., Giavaresi G., and Giardino R. In vitro osteoinduction of demineralized bone. Artif. Cells Blood Substit. Immobil. Biotechnol. 26 (1998) 309-315
30. Davis M.E., Lanzl L.H., and Strandjord N.M. Estrogens and the aging process. The detection, prevention, and retardation of osteoporosis. JAMA 196 (1966) 219-224
31. Lafferty F.W., Spencer Jr. G.E., and Pearson O.H. Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosis. Am. J. Med. 36 (1964) 514-528
32. Sylvia V.L., Boyan B.D., Dean D.D., and Schwartz Z. The membrane effects of 17beta-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J. Steroid Biochem. Mol. Biol. 73 (2000) 211-224
33. Sylvia V.L., Walton J., Lopez D., Dean D.D., Boyan B.D., and Schwartz Z. 17 beta-estradiol-BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J. Cell. Biochem. 81 (2001) 413-429
34. McMillan J., Fatehi-Sedeh S., Sylvia V.L., Bingham V., Zhong M., Boyan B.D., et al. Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways. Biochim. Biophys. Acta 1763 (2006) 381-392
35. Lohmann C.H., Tandy E.M., Sylvia V.L., Hell-Vocke A.K., Cochran D.L., Dean D.D., et al. Response of normal female human osteoblasts (NHOst) to 17beta-estradiol is modulated by implant surface morphology. J. Biomed. Mater. Res. 62 (2002) 204-213
36. Nilsson A., Ohlsson C., Isaksson O.G., Lindahl A., and Isgaard J. Hormonal regulation of longitudinal bone growth. Eur. J. Clin. Nutr. 48 Suppl. 1 (1994) S150-S158 (discussion S58-60)
37. Gao Y., Qian W.P., Dark K., Toraldo G., Lin A.S., Guldberg R.E., et al. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16618-16623
38. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13960-13965
39. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., and Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2 (1996) 1132-1136
40. Manolagas S.C., Bellido T., and Jilka R.L. Sex steroids, cytokines and the bone marrow: new concepts on the pathogenesis of osteoporosis. Ciba Found. Symp. 191 (1995) 187-196 (discussion 97-202)
41. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11 (1996) 1043-1051
42. Traianedes K., Russell J.L., Edwards J.T., Stubbs H.A., Shanahan I.R., and Knaack D. Donor age and gender effects on osteoinductivity of demineralized bone matrix. J. Biomed. Mater. Res., B Appl. Biomater. 70 (2004) 21-29
43. Edwards J.T., Diegmann M.H., and Scarborough N.L. Osteoinduction of human demineralized bone: characterization in a rat model. Clin. Orthop. Relat. Res. (1998) 219-228
44. Schwartz Z., Somers A., Mellonig J.T., Carnes Jr. D.L., Dean D.D., Cochran D.L., et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J. Periodontol. 69 (1998) 470-478
45. Roggia C., Tamone C., Cenci S., Pacifici R., and Isaia G.C. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med. 95 (2004) 125-132
46. Vaessen L.M., Broekhuizen R., Rozing J., Vos J.G., and Schuurman H.J. T-cell development during ageing in congenitally athymic (nude) rats. Scand. J. Immunol. 24 (1986) 223-235
47. Sass D.A., Liss T., Bowman A.R., Rucinski B., Popoff S.N., Pan Z., et al. The role of the T-lymphocyte in estrogen deficiency osteopenia. J. Bone Miner. Res. 12 (1997) 479-486
48. Wlodarski K.H., and Reddi A.H. Importance of skeletal muscle environment for ectopic bone induction in mice. Folia Biol. (Krakow) 34 (1986) 425-434
49. Kimble R.B., Bain S., and Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J. Bone Miner. Res. 12 (1997) 935-941
50. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., and Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94 (1994) 2397-2406
51. Boskey A.L., Rimnac C.M., Bansal M., Federman M., Lian J., and Boyan B.D. Effect of short-term hypomagnesemia on the chemical and mechanical properties of rat bone. J. Orthop. Res. 10 (1992) 774-783
52. Ornoy A., Giron S., Aner R., Goldstein M., Boyan B.D., and Schwartz Z. Gender dependent effects of testosterone and 17 beta-estradiol on bone growth and modelling in young mice. Bone Miner. 24 (1994) 43-58
53. Schwartz Z., Somers A., Mellonig J.T., Carnes Jr. D.L., Wozney J.M., Dean D.D., et al. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J. Periodontol. 69 (1998) 1337-1345
54. Boyan B.D., Lohmann C.H., Somers A., Niederauer G.G., Wozney J.M., Dean D.D., et al. Potential of porous poly-d,l-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J. Biomed. Mater. Res. 46 (1999) 51-59
55. Cesnjaj M., Stavljenic A., and Vukicevic S. Decreased osteoinductive potential of bone matrix from ovariectomized rats. Acta Orthop. Scand. 62 (1991) 471-475
56. Nasatzky E., Schwartz Z., Boyan B.D., Soskolne W.A., and Ornoy A. Sex-dependent effects of 17-beta-estradiol on chondrocyte differentiation in culture. J. Cell. Physiol. 154 (1993) 359-367
57. Schwartz Z., Finer Y., Nasatzky E., Soskolne W.A., Dean D.D., Boyan B.D., et al. The effects of 17 beta-estradiol on chondrocyte differentiation are modulated by vitamin D3 metabolites. Endocrine 7 (1997) 209-218
58. Nasatzky E., Grinfeld D., Boyan B.D., Dean D.D., Ornoy A., and Schwartz Z. Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-estradiol. Endocrine 11 (1999) 241-249
59. Ornoy A. Transplacental effects of estrogen on osteogenesis in rat foetuses. Pathology 5 (1973) 183-188
60. Movsowitz C., Epstein S., Fallon M., Ismail F., and Thomas S. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 123 (1988) 2571-2577
61. Finkelman RD. Re: Effect of estrogen and calcitonin therapies on bone density in a lateral area adjacent to implants placed in the tibiae of ovariectomized rats. Duarte PM, Cesar-Neto JB, Sallum AW, Sallum EA, Nociti FH Jr 2003;74:1618-24. Re: Guest editorial. Consideration of systemic hormone status when treating patients with osteopenia. Boyan BD, Schwartz Z 2003;74:1692-93. J Periodontol 2004;75:1742-3.
62. Duarte P.M., Cesar-Neto J.B., Sallum A.W., Sallum E.A., and Nociti Jr. F.H. Effect of estrogen and calcitonin therapies on bone density in a lateral area adjacent to implants placed in the tibiae of ovariectomized rats. J. Periodontol. 74 (2003) 1618-1624
63. Boyan B.D., and Schwartz Z. Consideration of systemic hormone status when treating patients with osteopenia. J. Periodontol. 74 (2003) 1692-1693